Norges Bank’s Accretive Health AH Stock Holding History

Norges Bank’s Portfolio AH Stock Details AH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-42,790	Closed	-$334K	–	2356
2014 Q2	$334K	Sell	42,790 -422,002	-91%	-$3.29M	﹤0.01%	2220
2014 Q1	$3.72M	Hold	464,792	–	–	﹤0.01%	1952
2013 Q4	$4.26M	Hold	464,792	–	–	﹤0.01%	1936
2013 Q3	$4.24M	Hold	464,792	–	–	﹤0.01%	1947
2013 Q2	$5.02M	Buy	+464,792	New	+$4.89M	﹤0.01%	1837

Other funds holding AH

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

ACM

Accipiter Capital Management Palm Beach Gardens, Florida $124M AUM 6.47% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

BCM

Breithorn Capital Management New York $141M AUM 41.82% 1-Year Est. Return

RMC

Regis Management Company Menlo Park, California $331M AUM 14.13% 1-Year Est. Return

ECM

EII Capital Management New York $774K AUM 22.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank's AH Position: Q3 2014 in Review

Norges Bank sold out of Accretive Health (AH) in Q3 2014, closing a stake of 42,790 shares — an estimated $334K sold.

Norges Bank first reported a position in AH in Q2 2013 and held it in 5 quarters. The position peaked at $5.02M in Q2 2013. 7 funds tracked by Wall St. Rank hold AH as of Q3 2014.

Norges Bank reported no remaining Accretive Health position as of Q3 2014 after selling out during the quarter.
Norges Bank sold 42,790 Accretive Health shares in Q3 2014, an estimated $334K.
Norges Bank first reported a position in Accretive Health in Q2 2013 and held it in 5 quarters.
Norges Bank's Accretive Health position peaked at $5.02M in Q2 2013.
7 funds tracked by Wall St. Rank held Accretive Health as of Q3 2014.

Based on Norges Bank's 13F filing for Q3 2014, filed 7 Nov 2014.